Inflammation Research Center,
UGent Center for Medical Biotechnology
Xavier Saelens has not added Biography.
If you are Xavier Saelens and would like to personalize this page please email our Author Liaison for assistance.
Proteolysis of enteric cell villin by Entamoeba histolytica cysteine proteinases.
The Journal of biological chemistry Jun, 2003 | Pubmed ID: 12690119
Mitochondrial intermembrane proteins in cell death.
Biochemical and biophysical research communications May, 2003 | Pubmed ID: 12729583
A Bcl-2 transgene expressed in hepatocytes does not protect mice from fulminant liver destruction induced by Fas ligand.
Cytokine May, 2003 | Pubmed ID: 12849704
Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death.
Acta haematologica , 2004 | Pubmed ID: 14646342
Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD.
The Journal of biological chemistry Feb, 2004 | Pubmed ID: 14668343
Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production.
Molecular biology of the cell Mar, 2004 | Pubmed ID: 14668480
Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity.
The Journal of biological chemistry Jun, 2004 | Pubmed ID: 15039421
Toxic proteins released from mitochondria in cell death.
Oncogene Apr, 2004 | Pubmed ID: 15077149
Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing.
Cellular signalling Jun, 2004 | Pubmed ID: 15093611
INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation.
The Journal of biological chemistry Dec, 2004 | Pubmed ID: 15383541
A novel caspase-2 complex containing TRAF2 and RIP1.
The Journal of biological chemistry Feb, 2005 | Pubmed ID: 15590671
Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 mediated cleavage of Raf-1.
Oncogene Feb, 2005 | Pubmed ID: 15674327
Protein synthesis persists during necrotic cell death.
The Journal of cell biology Feb, 2005 | Pubmed ID: 15699214
Necrosis is associated with IL-6 production but apoptosis is not.
Cellular signalling Mar, 2006 | Pubmed ID: 16023831
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.
Vaccine Jan, 2006 | Pubmed ID: 16169634
Improved design and intranasal delivery of an M2e-based human influenza A vaccine.
Vaccine Nov, 2006 | Pubmed ID: 16814430
Proteome-wide Identification of HtrA2/Omi Substrates.
Journal of proteome research Mar, 2007 | Pubmed ID: 17266347
Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis.
Arthritis research & therapy , 2007 | Pubmed ID: 17280603
CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.
Vaccine Feb, 2008 | Pubmed ID: 18243429
An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.
The Journal of biological chemistry Apr, 2008 | Pubmed ID: 18252707
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
Vaccine Dec, 2008 | Pubmed ID: 18835315
Pandemic preparedness: toward a universal influenza vaccine.
Drug news & perspectives Mar, 2009 | Pubmed ID: 19330167
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.
Expert review of vaccines Apr, 2009 | Pubmed ID: 19348565
Role of IFN-alpha during the acute stage of a swine influenza virus infection.
Research in veterinary science Feb, 2010 | Pubmed ID: 19647281
M2e-based universal influenza A vaccine.
Vaccine Oct, 2009 | Pubmed ID: 19840661
The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal.
Cell research Apr, 2010 | Pubmed ID: 20125124
Controlling influenza by cytotoxic T-cells: calling for help from destroyers.
Journal of biomedicine & biotechnology , 2010 | Pubmed ID: 20508820
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective.
The Journal of general virology Feb, 2011 | Pubmed ID: 20965983
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
Journal of immunology (Baltimore, Md. : 1950) Jan, 2011 | Pubmed ID: 21169548
The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections.
British journal of pharmacology Sep, 2011 | Pubmed ID: 21418188
Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection.
The Journal of infectious diseases Apr, 2011 | Pubmed ID: 21450996
A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus.
Vaccine May, 2011 | Pubmed ID: 21481325
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules.
PloS one , 2011 | Pubmed ID: 21483777
Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitro.
PloS one , 2011 | Pubmed ID: 21935489
Nanobodies®: new ammunition to battle viruses.
Antiviral research Dec, 2011 | Pubmed ID: 21939690
Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
The Journal of infectious diseases Dec, 2011 | Pubmed ID: 21998474
Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infection.
ACS nano Mar, 2012 | Pubmed ID: 22303914
Tailor-made cleavage site attenuates influenza B.
Expert review of vaccines Feb, 2012 | Pubmed ID: 22309664
A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection.
PLoS pathogens , 2012 | Pubmed ID: 22396652
The Sin3a repressor complex is a master regulator of STAT transcriptional activity.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2012 | Pubmed ID: 22783022
Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection.
The Journal of biological chemistry Oct, 2012 | Pubmed ID: 22910914
Influenza vaccines: T-cell responses deserve more attention.
Expert review of vaccines Aug, 2012 | Pubmed ID: 23002976
Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly.
Journal of virology Dec, 2012 | Pubmed ID: 23015724
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
PloS one , 2012 | Pubmed ID: 23029232
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.
Journal of virology Mar, 2013 | Pubmed ID: 23302879
Hepatitis B core-based virus-like particles to present heterologous epitopes.
Expert review of vaccines Feb, 2013 | Pubmed ID: 23414409
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.
PloS one , 2013 | Pubmed ID: 23527091
Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.
PloS one , 2013 | Pubmed ID: 23555631
Insight into structural diversity of influenza virus haemagglutinin.
The Journal of general virology Aug, 2013 | Pubmed ID: 23636824
Challenges and advances towards the rational design of mRNA vaccines.
Trends in molecular medicine Dec, 2013 | Pubmed ID: 24138818
Metabolic profiling of insect cell lines: Unveiling cell line determinants behind system's productivity.
Biotechnology and bioengineering Apr, 2014 | Pubmed ID: 24258249
Mx proteins: antiviral gatekeepers that restrain the uninvited.
Microbiology and molecular biology reviews : MMBR Dec, 2013 | Pubmed ID: 24296571
Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin.
PloS one , 2014 | Pubmed ID: 24587046
Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro.
Antimicrobial agents and chemotherapy Jul, 2014 | Pubmed ID: 24752266
Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.
Journal of virology Aug, 2014 | Pubmed ID: 24829341
Influenza vaccines to control influenza-associated bacterial infection: where do we stand?
Expert review of vaccines Jan, 2015 | Pubmed ID: 25209381
CD⁸ T cell immunity against human respiratory syncytial virus.
Vaccine Oct, 2014 | Pubmed ID: 25223272
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.
EMBO molecular medicine Nov, 2014 | Pubmed ID: 25298406
Sequence-dependent internalization of aggregating peptides.
The Journal of biological chemistry Jan, 2015 | Pubmed ID: 25391649
Structure of the extracellular domain of matrix protein 2 of influenza a virus in complex with a protective monoclonal antibody.
Journal of virology Apr, 2015 | Pubmed ID: 25609808
Scop3D: Three-dimensional visualization of sequence conservation.
Proteomics Apr, 2015 | Pubmed ID: 25641949
Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing.
BMC genomics , 2015 | Pubmed ID: 25758772
Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.
Immunotherapy Mar, 2015 | Pubmed ID: 25804473
A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody.
PloS one , 2015 | Pubmed ID: 25816132
The C terminus of NS1 protein of influenza A/WSN/1933(H1N1) virus modulates antiviral responses in infected human macrophages and mice.
The Journal of general virology Aug, 2015 | Pubmed ID: 25934792
Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
PloS one , 2015 | Pubmed ID: 25973787
Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.
Journal of virology Nov, 2015 | Pubmed ID: 26292322
M2e-Based Universal Influenza A Vaccines.
Vaccines Feb, 2015 | Pubmed ID: 26344949
Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody.
Journal of virology Oct, 2015 | Pubmed ID: 26468526
GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation.
The Journal of allergy and clinical immunology Mar, 2016 | Pubmed ID: 26560044
Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-κB signaling.
European journal of immunology Apr, 2016 | Pubmed ID: 26677802
Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine.
Antiviral research Feb, 2016 | Pubmed ID: 26738783
A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection.
PLoS pathogens Jan, 2016 | Pubmed ID: 26815999
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.
Scientific reports Apr, 2016 | Pubmed ID: 27072615
Production and Purification of Recombinant Filamentous Bacteriophages Displaying Immunogenic Heterologous Epitopes.
Methods in molecular biology (Clifton, N.J.) , 2016 | Pubmed ID: 27076317
One Against All: A Broadly Influenza Neutralizing Man-made Monoclonal Antibody Passes Phase I.
EBioMedicine Mar, 2016 | Pubmed ID: 27077102
Illumina MiSeq sequencing disfavours a sequence motif in the GFP reporter gene.
Scientific reports May, 2016 | Pubmed ID: 27193250
Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages.
Molecular & cellular proteomics : MCP Oct, 2016 | Pubmed ID: 27486199
Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses.
Molecular therapy : the journal of the American Society of Gene Therapy Nov, 2016 | Pubmed ID: 27506450
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Journal of virology Nov, 2016 | Pubmed ID: 27581985
M2-based influenza vaccines: recent advances and clinical potential.
Expert review of vaccines Feb, 2017 | Pubmed ID: 27653543
Influenza and Memory T Cells: How to Awake the Force.
Vaccines Oct, 2016 | Pubmed ID: 27754364
Regulation of kynurenine biosynthesis during influenza virus infection.
The FEBS journal Jan, 2017 | Pubmed ID: 27860276
Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1.
The Journal of biological chemistry Feb, 2017 | Pubmed ID: 28011636
Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.
Journal of virology Apr, 2017 | Pubmed ID: 28077656
IgG3 Snitcher of RSV Infections in the Very Young.
EBioMedicine Feb, 2017 | Pubmed ID: 28159571
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.
Nature communications Feb, 2017 | Pubmed ID: 28194013
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection.
Antiviral research May, 2017 | Pubmed ID: 28257797
Effect of serial pig passages on the adaptation of an avian H9N2 influenza virus to swine.
PloS one , 2017 | Pubmed ID: 28384328
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유